Table 4 Hazard ratios for survival from stepwise, backward, and multivariate Cox hazard regression after multiple imputation (40 imputations)

From: Prognostic role of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in patients with bone metastases

 

HR

95% Confidence interval

p value

Age

1.013

1.007–0.019

<0.001

Location skeleton

0.167

1.010–1.349

0.036

Category 1 (slow growth)

Reference

  

Category 2 (moderate growth)

1.580

1.318–1.895

<0.001

Category 3 (rapid growth)

2.918

2.450–3.475

<0.001

Other bone metastases

1.201

1.029–1.401

0.020

Visceral metastases

1.544

1.333–1.789

<0.001

Previous systemic therapy

1.233

1.063–1.431

0.006

Hemoglobin

0.890

0.851–0.931

<0.001

NLR

1.311

1.117–1.538

0.001

PLR

1.358

1.152–1.601

<0.001

  1. NLR neutrophil-to-lymphocyte ratio, PLR  platelet-to-lymphocyte ratio
Back to article page